Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term lacosamide monotherapy and adjunctive therapy in partial-onset seizures (open-label extension)
2007-005440-25Phase 3Completed
- Sponsor
- UCB
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in Focal onset seizure and focal onset impaired awareness seizure, sponsored by UCB. Primary endpoint: Long-term use of lacosamide monotherapy. Started Jul 2008; status: completed.
02
Drugs
lacosamide
03
Conditions
Focal onset seizurefocal onset impaired awareness seizure
Beyond the preview
Go deeper on 2007-005440-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005440-25.